Skip to main content
. 2021 Oct 15;13(20):5173. doi: 10.3390/cancers13205173

Figure 3.

Figure 3

Genomic aberrations found by SNPa in cases with heterogeneous MYCN amplification (hetMNA). In the upper part the number of the analysed samples (T: solid tumour -1, 2, 3-; LB: liquid biopsy) corresponding to each case (53–58) with the total number of SCAs and the typical ones in parenthesis, are shown. Solid blue Inline graphic or red Inline graphic squares refers to gains or losses, respectively in the indicated chromosome arm. Gradient color from blue Inline graphic or red Inline graphic to black indicates gains or losses with 2 or more chromosome fragments in the chromosome arm. Gradient color from blue to red Inline graphic refers to both gains and losses in the same chromosome arm of a sample. Solid yellow squares Inline graphic indicate presence of chromotripsis-like phenomenon. Green squares Inline graphic indicate MYCN amplification detection by SNPa. Black squares Inline graphic indicate presence of focal segmental chromosomal aberrations (FSCAs) affecting TERT or ATRX genes. Purple squares Inline graphic indicate that the samples have been analysed for alternative lengthening of telomeres (ALT) or for mutations and amplifications in ALK gene; NA: in the squares indicates that any aberration has been detected in the sample.